Skip Navigation

Publicaciones covid-9

Resource Feedback

If you know about a problem with one of our resource records, we want to know about it!

Resource Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)
URL https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00113-4/fulltext
(if you would like a response)
Verification Code:
CAPTCHA Image
Reload Image